Complete Blood Count Device; Used to Screen for Diseases as Part of Medical Assessment



 Complete blood count devices are medical devices often used to screen for diseases as part of a medical assessment. These devices are used to measure the amounts of platelets, white blood cells, and red blood cells, as well as the hemoglobin and hematocrit values. They can either be portable or stationary. Portable devices are used to screen various diseases, such as leukemia, anemia, and blood infection, as well as routine checkup of glucose in diabetic patients. While, stationary devices are used to conduct multiple blood tests.

Stationary complete blood count devices are mostly used in hospitals, diagnostics laboratories, and other large facilities, while portable once are used mostly used in home care settings. The CBC (complete blood count) is performed using an automated hematology analyzer or basic laboratory equipment, which counts cells and collects information on their size and structure. The concentration of hemoglobin is also measured, and red blood cell indices are calculated from the measurement of red blood cells and hemoglobin. A complete blood count is a common blood test that's done for a variety of reasons. The global complete blood count device market is expected to exhibit a CAGR of 8.3% during the forecast period

Automated hematology analyzers can rapidly analyze whole blood specimens for the complete blood count (CBC). Results include white blood cell count, red blood cell count, platelet count, RBC indices, hematocrit, hemoglobin concentration, and a leukocyte differential. Hematology analyzer performs a qualitative and quantitative analysis of the formed elements of the blood; red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes).

A doctor may recommend a complete blood count as part of a routine medical examination to monitor a patient’s health and to screen for a variety of disorders, such as leukemia and anemia. Thus, with the increasing prevalence of blood disease or infection, the demand for complete blood count devices is also increasing. For example, in December 2020, Nihon Kohden (Japan) announced the launch of MEK-1305 Celltac α+, an Automated Hematology & ESR Analyzer, which can measure complete blood count.

Nihon Kohden developed MEK-1305 based on the concept of providing rapid and accurate test results, which are important for understanding the clinical condition of patients.

Post a Comment

Previous Post Next Post